Fad (flavin Adenine Dinucleotide) And Derivatives Thereof Patents (Class 536/26.25)
  • Publication number: 20110177316
    Abstract: The invention relates to a method for producing a biodegradable molded part, comprising: providing a binding agent which contains a lyzable biopolymer; forming a molded part from the binding agent, wherein the time stability of the molded part to biological lysis is set by at least one of the following measures: adding a pulverized inorganic solid matter in a proportion of 5% to 85% of the mass of the binding agent before forming the molded part; thawing at least one of the surfaces of the molded part using a chemical or biological method such that the surface has a structuring in the range between 1 nm and 10 ?m. The invention further relates to an accordingly produced molded part.
    Type: Application
    Filed: October 3, 2008
    Publication date: July 21, 2011
    Applicant: LEONARDIS-STIFTUNG
    Inventors: Klaus Rennebeck, Bernd Hildenbrand
  • Patent number: 7202340
    Abstract: Nitrosylhemoglobin can be produced by introducing gaseous NO into an aqueous solution of hemoglobin. It has been demonstrated that nitrosylhemoglobin in aqueous solution can be converted to SNO-hemoglobin upon introduction of oxygen to the solution, as is postulated to occur in the lungs. Nitrosylhemoglobin can be used in methods to produce the physiological effects of NO, for example, to reduce vasoconstriction and to inhibit platelet aggregation.
    Type: Grant
    Filed: August 11, 2003
    Date of Patent: April 10, 2007
    Assignee: Duke University
    Inventors: Jonathan S. Stamler, Andrew J. Gow
  • Patent number: 6207649
    Abstract: The invention relates to pharmaceutical compositions of nucleoside dimers containing an L-sugar in at least one of the nucleosides.
    Type: Grant
    Filed: December 23, 1998
    Date of Patent: March 27, 2001
    Assignee: Lipitek International, Inc.
    Inventors: Alexander L Weis, Kirupathevy Pulenthiran